Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Unraveling the Dynamics of T Cell-Dependent Bispecific Antibodies in Multiple Myeloma: Multi-Omic Insights from Primary Patient Cells

Dennis J Wu, Amy S Chen, Nikki Deangelis, Diana Cortes, Jose Morachis, Benjamin Titz, Sylvaine Cases, Raluca Verona, Chorom Pak

Blood (2023) 142 (Supplement 1): 3659.

https://doi.org/10.1182/blood-2023-190245

Published: 2023

Journal Articles

Clonal Dynamics of ASM-AHN with Avapritinib Treatment

Xiaomeng Huang, Jonathan M. Ahmann, Opal S. Chen, Yi Qiao, Anthony D. Pomicter, Gabor T. Marth, Tracy I. George, Michael W. Deininger

Blood (2022) 140 (Supplement 1): 6737–6738.

https://doi.org/10.1182/blood-2022-167701

Published: 2022

Journal Articles

Pharmacological Profiling of Cells from Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Pirtobrutinib

Shady I. Tantawy, Burcu Aslan, Lisa S Chen, Lakesla Iles, Philip A. Thompson, Nitin Jain, William G. Wierda, Varsha Gandhi

Blood (2022) 140 (Supplement 1): 501–502.

https://doi.org/10.1182/blood-2022-171119

Published: 2022

Journal Articles

Venetoclax Synergizes with the RNA-Directed Nucleoside Analog 8-Chloro-Adenosine in Acute Myeloid Leukemia in Vitro and In Vivo

Ralf Buettner, PhD, Le Xuan Truong Nguyen, PhD, Corey James Morales, BA, BS, Lisa S Chen, PhD, Timothy Synold, PhD, Dinh Hoa Hoang, BS, Bin Amber Zhang, PhD, Lucy Ghoda, PhD, Varsha Gandhi, PhD, Vinod A. Pullarkat, MD, Guido Marcucci, MD, Steven T. Rosen, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-143240

Published: 2020

Journal Articles

Translational and Clinical Evidence of a Differentiated Profile for the Novel CELMoD, Iberdomide (CC-220)

Blood (2019) 134 (Supplement_1): 3119.

https://doi.org/10.1182/blood-2019-124298

Published: 2019

Journal Articles

Antileukemic Activity of 8-Chloro-Adenosine (8-Cl-Ado) Is Mediated By Mir-155 Degradation and ErbB3 Binding Protein (Ebp1)-Dependent p53 Activation: A Novel Therapeutic Approach for FLT3-ITD Acute Myeloid Leukemia (AML)

Blood (2018) 132 (Supplement 1): 3938.

https://doi.org/10.1182/blood-2018-99-119880

Published: 2018

Journal Articles

A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia

Lisa S. Chen, Prithviraj Bose, Nichole D. Cruz, Yongying Jiang, Qi Wu, Philip A. Thompson, Shuju Feng, Michael H. Kroll, Wei Qiao, Xuelin Huang, Nitin Jain, William G. Wierda, Michael J. Keating, Varsha Gandhi

Blood (2018) 132 (21): 2249–2259.

https://doi.org/10.1182/blood-2018-06-860593

Published: 2018

Includes: Supplemental data

Journal Articles

8-Chloro-Adenosine Inhibits Molecular Poor-Risk Acute Myeloid Leukemia (AML) and Leukemic Stem Cells (LSC) Growth and Synergizes with the BCL-2 Inhibitor Venetoclax (ABT-199)

Ralf Buettner, PhD, Ching-Cheng Chen, PhD, Bijender Kumar, PhD, Corey Morales, BA, BS, Lisa S Chen, PhD, Krister Wennerberg, PhD, Ryan Thompson, MS, Tea Pemovska, MSc, Ling Li, PhD, Bin Zhang, PhD, Claudia Kowolik, PhD, Mika Kontro, MD, Calum Leitch, MD, David Horne, PhD, Joycelynne Palmer, PhD, Varsha Gandhi, PhD, Guido Marcucci, MD, Vinod Pullarkat, MD, Steven T. Rosen, MD

Blood (2016) 128 (22): 2758.

https://doi.org/10.1182/blood.V128.22.2758.2758

Published: 2016

Journal Articles

8-Chloro-Adenosine Inhibits Molecular Poor-Risk Acute Myeloid Leukemia (AML) and Leukemic Stem Cells (LSC) Growth Via Novel RNA- and ATP-Directed Mechanisms: A Novel Therapeutic Approach for AML

Ralf Buettner, PhD, Ching-Cheng Chen, PhD, Bijender Kumar, PhD, Lisa S Chen, PhD, Krister Wennerberg, PhD, Ryan Thompson, MS, Tea Pemovska, MSc, Ling Li, PhD, Varsha Gandhi, PhD, Guido Marcucci, MD, Vinod Pullarkat, MD, Steven T. Rosen, MD

Blood (2015) 126 (23): 792.

https://doi.org/10.1182/blood.V126.23.792.792

Published: 2015

Journal Articles

A Phase 1, Multicenter Study of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone in Patients with Proteasome Inhibitor Exposed and Lenalidomide-Refractory Myeloma (Trial MM-005)

Paul G. Richardson, MD, Craig Hofmeister, Noopur S. Raje, MD, David Siegel, MD PhD, Sagar Lonial, MD, Jacob P. Laubach, Yvonne A Efebera, MD, David H. Vesole, MD, Ajay K Nooka, Jacalyn Rosenblatt, Mohamed H Zaki, Jennifer Herring, Yan Li, PhD, Sheetal Shah, Min S Chen, Kenneth C Anderson

Blood (2015) 126 (23): 3036.

https://doi.org/10.1182/blood.V126.23.3036.3036

Published: 2015

Journal Articles

Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race

Leonard C. Edelstein, Lukas M. Simon, Cory R. Lindsay, Xianguo Kong, Raúl Teruel-Montoya, Benjamin E. Tourdot, Edward S. Chen, Lin Ma, Shaun Coughlin, Marvin Nieman, Michael Holinstat, Chad A. Shaw, Paul F. Bray

Blood (2014) 124 (23): 3450–3458.

https://doi.org/10.1182/blood-2014-04-572479

Published: 2014

Includes: Supplemental data

Journal Articles

Blood collection methods affect cellular protein integrity: implications for clinical trial biomarkers and ZAP-70 in CLL

Lisa S. Chen, Michael J. Keating, Varsha Gandhi

Blood (2014) 124 (7): 1192–1195.

https://doi.org/10.1182/blood-2014-04-565754

Published: 2014

Journal Articles

Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics

Lukas M. Simon, Leonard C. Edelstein, Srikanth Nagalla, Angela B. Woodley, Edward S. Chen, Xianguo Kong, Lin Ma, Paolo Fortina, Satya Kunapuli, Michael Holinstat, Steven E. McKenzie, Jing-fei Dong, Chad A. Shaw, Paul F. Bray

Blood (2014) 123 (16): e37–e45.

https://doi.org/10.1182/blood-2013-12-544692

Published: 2014

Includes: Supplemental data

Journal Articles

Cytoplasmic globules in erythroid blasts and CLL

Preetesh Jain, Su S. Chen

Blood (2013) 121 (17): 3305.

https://doi.org/10.1182/blood-2012-11-467837

Published: 2013

Journal Articles

Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma

Qingshan Yang, Lisa S. Chen, Sattva S. Neelapu, Roberto N. Miranda, L. Jeffrey Medeiros, Varsha Gandhi

Blood (2012) 120 (17): 3491–3500.

https://doi.org/10.1182/blood-2012-02-412643

Published: 2012

Includes: Supplemental data

Journal Articles

Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia

Lisa S. Chen, Sanjeev Redkar, Pietro Taverna, Jorge E. Cortes, Varsha Gandhi

Blood (2011) 118 (3): 693–702.

https://doi.org/10.1182/blood-2010-12-323022

Published: 2011

Includes: Supplemental data

Journal Articles

Human UCB CD133 + Cell Infusion In NOD-SCID Mice with Acute Hind Limb Ischemia Improves Reperfusion of An Ischemic Bed

Mathew Lesniewski, PhD, Jonathan Goldberg, MD, Laura Fanning-Hammond, MS, Marcie Finney, MS, Margaret Forster, MS, Cindy S. Chen, BS, R. Patrick Weitzel, PhD, Patrick Leahy, PhD, Nicholas J Greco, PhD, Mary J. Laughlin, MD

Blood (2010) 116 (21): 4697.

https://doi.org/10.1182/blood.V116.21.4697.4697

Published: 2010

Journal Articles

Uncommon BCR-ABL kinase domain mutations in kinase inhibitor–resistant chronic myelogenous leukemia and Ph + acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects

Dan Jones, Su S. Chen, Elias Jabbour, Mary Beth Rios, Hagop Kantarjian, Jorge Cortes

Blood (2010) 115 (26): 5428–5429.

https://doi.org/10.1182/blood-2009-11-252155

Published: 2010

Includes: Supplemental data

Journal Articles

Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells

Lisa S. Chen, Sanjeev Redkar, David Bearss, William G. Wierda, Varsha Gandhi

Blood (2009) 114 (19): 4150–4157.

https://doi.org/10.1182/blood-2009-03-212852

Published: 2009

Includes: Supplemental data

Journal Articles

Pim Kinase Inhibitor, SGI-1776, Induces Apoptosis in CLL Lymphocytes

Lisa S Chen, Ph.D, William G Wierda, M.D., Ph.D, Sanjeev Redkar, Ph.D, David J. Bearss, PhD, Varsha Gandhi, Ph.D

Blood (2008) 112 (11): 4199.

https://doi.org/10.1182/blood.V112.11.4199.4199

Published: 2008

NARROW

Unraveling the Dynamics of T Cell-Dependent Bispecific Antibodies in Multiple Myeloma: Multi-Omic Insights from Primary Patient Cells

Clonal Dynamics of ASM-AHN with Avapritinib Treatment

Pharmacological Profiling of Cells from Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Pirtobrutinib

Venetoclax Synergizes with the RNA-Directed Nucleoside Analog 8-Chloro-Adenosine in Acute Myeloid Leukemia in Vitro and In Vivo

Translational and Clinical Evidence of a Differentiated Profile for the Novel CELMoD, Iberdomide (CC-220)

Antileukemic Activity of 8-Chloro-Adenosine (8-Cl-Ado) Is Mediated By Mir-155 Degradation and ErbB3 Binding Protein (Ebp1)-Dependent p53 Activation: A Novel Therapeutic Approach for FLT3-ITD Acute Myeloid Leukemia (AML)

A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia

8-Chloro-Adenosine Inhibits Molecular Poor-Risk Acute Myeloid Leukemia (AML) and Leukemic Stem Cells (LSC) Growth and Synergizes with the BCL-2 Inhibitor Venetoclax (ABT-199)

8-Chloro-Adenosine Inhibits Molecular Poor-Risk Acute Myeloid Leukemia (AML) and Leukemic Stem Cells (LSC) Growth Via Novel RNA- and ATP-Directed Mechanisms: A Novel Therapeutic Approach for AML

A Phase 1, Multicenter Study of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone in Patients with Proteasome Inhibitor Exposed and Lenalidomide-Refractory Myeloma (Trial MM-005)

Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race

Blood collection methods affect cellular protein integrity: implications for clinical trial biomarkers and ZAP-70 in CLL

Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics

Cytoplasmic globules in erythroid blasts and CLL

Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma

Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia

Human UCB CD133 + Cell Infusion In NOD-SCID Mice with Acute Hind Limb Ischemia Improves Reperfusion of An Ischemic Bed

Uncommon BCR-ABL kinase domain mutations in kinase inhibitor–resistant chronic myelogenous leukemia and Ph + acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects

Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells

Pim Kinase Inhibitor, SGI-1776, Induces Apoptosis in CLL Lymphocytes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only